Stimulating Sports & Science

Stimulating Sports & Science

New ideas are abundant. When we encounter one, we have a choice to make: do we embrace it or do we reject it? Too often, the very old, very conservative, very resistant to change, are too set in their ways and say: “that will never work.” Our job is to find those who see to ask and answer: “What if it does?”

At Lux, meeting and investing in pioneering and rebellious scientists, we’re often reminded of the danger in mental shortcuts that would otherwise leave us thinking: “That can’t be!”

Enter Halo Neuroscience co-founders Drs. Daniel Chao and Brett Weingeier. Both spent more than a decade working together at Neuropace, where they developed the world’s first implanted, responsive neurostimulator for epilepsy treatment. After nearly 15 years of work, the device was approved by the FDA in 2013. A patient may have hundreds of seizures a day, but the implant senses the onset of an epileptic episode and applies a counteracting stimulus automatically. With the device, the patient can be free to live a normal life. Adding to decades of progress in treatment of neurological disorders, this demonstrated the great potential of neurostimulation to improve human health and physical performance.

Yet Dan, Brett and co-founder Dr. Amol Sarva wondered: what broader impact could you create with a neurostimulating device that doesn’t need invasive brain surgery? The founders saw that similar effects could result from external neurostimulators without being implanted. External neurostimulation can activate specific parts of the brain in healthy populations and help trigger optimal physical performance for sports training. Drawing on decades of neuroscience research and dozens of studies, the Halo team created a new device: Halo Sport. Simple to use, beautifully designed, and rigorously tested to produce real results.

Some of our team found it hard to believe. No wonder, since advances in science and technology sometimes feel like magic. Elite Olympic and professional athletes might have initially been skeptical too — but now they and their teams are using Halo Sport to dramatically improve performance. The foundation of Halo Neuroscience is based on verifiable science that keeps advancing and improving. We’re excited at Lux to be seed and Series A lead investors in Halo Neuroscience, supporting Dan and Brett’s bold and ambitious vision.

written by
Peter Hébert
Co-founder and Managing Partner

Peter co-founded Lux Capital with the idea that in order to have the biggest impact on the future, one should support the most scientifically and technologically ambitious ventures. His goal: to seek out founders developing things most people thought would not work, yet if they did, would become so intrinsic to our way of life that we would someday take them for granted.

Today Lux supports a wide range of once-impossible-sounding advancements, including 3D printing and imaging, nuclear waste cleanup, machine learning and robots that fly or conduct microsurgery.

Imitation is suicide. –Ralph Waldo Emerson

Peter led Lux’s investments in Auris Health (acquired by Johnson & Johnson for up to $6 billion, making it one of top 10 VC-backed private M&A transactions of all-time), Everspin Technologies (NASDAQ: MRAM), Lux Research (acquired by Bregal Sagemount), Luxtera (acquired by Cisco for $660 million), Matterport (NASDAQ: MTTR), SiBEAM (acquired by Silicon Image), Transphorm (NASDAQ: TGAN), and Vium (acquired by Recursion). Peter launched the firm’s Lux Health + Tech investment strategy, including the Nasdaq Lux Health Tech Index (NASDAQ: NQHTEC) and helped launch the First Trust Nasdaq Lux Digital Health Solutions ETF (NASDAQ: EKG). Current investments include Avail, Bright Machines, Carbon Health, Flex Logix, Ingenuity, Lux Health Tech Acquisition Corp. (NASDAQ: LUXA), Mendaera, Ripcord, Thematic and Vosbor. In 2003, Peter led the spin-off of Lux Research. As its founding CEO, he helped build Lux Research into the leading emerging-technology research firm. In 2021, he co-founded Thematic as a next generation index and ETF developer and today serves as its Chairman.

Peter began his career at Lehman Brothers, where he worked in the firm’s top-ranked Equity Research group. He was a Chancellor’s Scholar and graduated cum laude from Syracuse University’s Newhouse School, and was the Founding President of its first venture organization, Future Business Leaders and Entrepreneurs. He has been a guest on CNBC and Bloomberg TV, and speaker at Columbia, Cornell, MIT, Stanford, Yale, and the National Science Foundation.

written by

Stimulating Sports & Science

visit source
Text Link